购物车
- 全部删除
- 您的购物车当前为空
(S)-10-Hydroxycamptothecin (10-HCPT) 是一种从喜树中分离的 DNA 拓扑异构酶 I 抑制剂。它显著诱导细胞凋亡,可研究肝癌、胃癌、结肠癌和白血病。
(S)-10-Hydroxycamptothecin (10-HCPT) 是一种从喜树中分离的 DNA 拓扑异构酶 I 抑制剂。它显著诱导细胞凋亡,可研究肝癌、胃癌、结肠癌和白血病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 336 | 现货 | |
50 mg | ¥ 497 | 现货 | |
100 mg | ¥ 788 | 现货 | |
500 mg | ¥ 1,930 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 547 | 现货 |
产品描述 | (S)-10-Hydroxycamptothecin (10-HCPT) is a DNA topoisomerase I inhibitor, utilized as a clinical therapy agent against hepatoma. |
体外活性 | 在CAM模型中,10-Hydroxycamptothecin(25 nM)以浓度依赖性方式抑制血管生成.在携带有Colo 205异种移植物小鼠中,每2天口服10-Hydroxycamptothecin(2.5-7.5 mg / kg),能够显著抑制肿瘤细胞生长. |
体内活性 | 在BT-20细胞(IC50=34.3 nM)和MDA-231细胞(IC50=7.27 nM)中,(S)-10-Hydroxycamptothecin抑制细胞生长。在pBR322质粒DNA中(EC50=0.35 μM), (S)-10-Hydroxycamptothecin有效诱导的人拓扑异构酶I介导的易解离复合物的形成。在人微血管内皮细胞(HMEC)中,(S)-10-Hydroxycamptothecin能够剂量依赖性的抑制细胞生长(IC50=0.31 μM),显着抑制HMEC的迁移(IC50=0.63 μM),抑制血管形成(IC50=0.96 μM)。 |
细胞实验 | Cells are exposed to various concentrations of 10-Hydroxycamptothecin for 72 hours. Cell growth is monitored by the standard MTT assay.(Only for Reference) |
别名 | 10-羟基喜树碱, 10-羟喜树碱, 10-Hydroxycamptothecin, 10-HCPT |
分子量 | 364.35 |
分子式 | C20H16N2O5 |
CAS No. | 19685-09-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 20 mg/mL (54.89 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.